ET-01 in Subjects With Lateral Canthal Lines

NCT03326856 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eirion Therapeutics Inc.